Precision Healthcare for Impaired Reality Testing

This session explores the presentation and treatment of psychotic symptoms. Focus is directed to the treatment of schizophrenia, an incurable neuropsychiatric disorder. Up to 34% of patients with schizophrenia have treatment-resistant schizophrenia. Most current treatments for schizophrenia have focused exclusively on dopamine, which can improve the positive symptoms of schizophrenia; however, these therapies are often associated with adverse effects. None of the currently available therapies were designed to specifically target the negative symptoms of schizophrenia. Recently, the development and investigation of agents targeting the muscarinic system have demonstrated that these agents may be viable treatment options for patients with schizophrenia and have been shown to improve the negative symptoms of schizophrenia. This session assesses the symptom and treatment burdens faced by patients with schizophrenia and examines the mechanisms of action, safety, and efficacy of emerging agents with novel therapeutic targets to treat all symptoms associated with schizophrenia.

Credits: 1.25 Contact Hours; 1.00 are Pharmacology
Expiration Date: December 31st, 2025

$35

LEARNING OBJECTIVES


After taking part in this educational activity, participants should be better able to:

-Conceptualize mental illness in a neurobiological context (with an emphasis on psychotic disorders). 
-Discuss current approaches to management of psychotic disorders, including practical applications for nurse practitioners. 
-Apply concepts of pharmacogenomics to the selection, prescription and management of drug therapy for psychotic disorders. 
- Explore and discuss novel pipeline pharmacotherapeutics for the treatment of psychosis.

Josh Hamilton, DNP, RN-BC, FNP-C, PMHNP-BC, CTMH, CNE, FAANP

President & Chief Clinical Officer

The Hamilton Group LLC

Josh Hamilton resides in Las Vegas, Nevada, where he practices Tele-psychiatry on a national scale. With more than a quarter-century of nursing experience, he also holds professorial appointments, academic leadership positions and provides extensive professional consultation services in higher education, industry and clinical affairs.

He was associate medical director for the largest managed care behavioral health network in the Desert Southwest and, as a university dean and vice president, he built one of the largest portfolio collections of competency-based graduate Nursing degrees in the United States.

His professional interests include neurobiology, pharmacology and epigenetics. He is an internationally-recognized speaker on these (and related) topics at conferences and professional meetings. He served on the psychiatric medication working group at the Center of Excellence in Regulatory Science & Innovation, a FDA-sponsored project at the University of Maryland.

He is a NEI Master Psychopharmacologist and a fellow of the American Association of Nurse Practitioners. The Point of Care Network proclaimed Josh to be America’s Top Psychiatric NP in 2021. He won the award again in 2024.

Learn more about Dr. Josh Hamilton at www.linkedin.com/in/hamiltondnp

CE INFORMATION


Obtain Your Credits

To earn credits for this activity, navigate to the Content(s) tab and complete all course components in the following order: 1) watch the course presentation video; 2) complete the course evaluation; 3) pass the post-test with a score of 2/3 (66.7%) or higher. You may retake the post-test until a passing score is achieved, at which point you will be able to view/print a copy of your certificate of completion. This online certificate will also be saved within your profile 'My Dashboard' -> 'Transcript/Certificates Earned'  for future access.

Designation Statement

NPACE designates this educational activity for a maximum of 1.25 contact hours, of which 1.00 is pharmacology credit. Participants should claim only credit commensurate with the extent of their participation in the activity.

Accreditation Statement

Nurse Practitioner Associates for Continuing Education (NPACE) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC).

In addition to ANCC, NPACE is approved as a provider of continuing education in nursing by: the California Board of Registered Nursing, Provider Number CEP8720 and Florida CE Broker #50-1476.

DISCLOSURES


Faculty

Contributing faculty, Josh Hamilton, DNP, RN-BC, FNP-C, PMHNP-BC, CNE, FAANP have disclosed:

Myriad Neuroscience, Speakers Bureau (ended 08/2023), PGx Testing Genesight
Tempus Labs, Inc., Consultant & Speakers Bureau, PGx Testing Tempus nP
Point of Care Network, Paid Ambassador, Various N/A

Planners

All planners and contributors involved in this educational activity have disclosed no relevant financial relationships. 

Disclaimer

The material presented in this continuing education program is being made available for educational purposes only and is not intended to represent the best or only methods, medications and/or guidelines appropriate for the medical situation discussed. Rather the material is intended to present an approach, view, statement, or opinion of the presenter(s), which may be helpful, or of interest to other practitioners and should not be used by clinicians without the evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. NPACE disclaims any liability, loss, injury, or damage incurred as a consequence, directly or indirectly, of the use and application of any information given in a presentation.

Disclosure of Unlabeled Use

This educational activity may mention the uses of products that are not approved by the FDA for the indication(s) being discussed. The presenter(s) are instructed to notify participants when they are discussing unapproved uses or investigational agents. The opinions related to unapproved uses of products are solely those of the presenter(s) and are not endorsed or recommended by NPACE. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Commercial Support

There is no commercial support for this activity.

Key:

Complete
Failed
Available
Locked
Pre-Test
3 Questions  |  1 attempt  |  0/3 points to pass
3 Questions  |  1 attempt  |  0/3 points to pass Please complete this pre-test prior to watching the presentation video - Simply click the 'Take Quiz' button. This pre-test is a non-graded assessment tool we use to establish a baseline and determine a participant's pre-existing knowledge.
Presentation Video
Open to view video.  |   Closed captions available
Open to view video.  |   Closed captions available Anxiously Awaited: Neurobiology & Personalized Treatment of Anxiety
Course Evaluation
9 Questions
Post-Test
3 Questions  |  Unlimited attempts  |  2/3 points to pass
3 Questions  |  Unlimited attempts  |  2/3 points to pass Pass this 3 question post-test with a score of 2/3 (66.7%) or higher.
Certificate
1.25 Contact Hours credits  |  Certificate available
1.25 Contact Hours credits  |  Certificate available You can now view/print a copy of your certificate of completion by clicking the button to the right. This online certificate will also be saved within your 'My Dashboard' --> 'Transcript/Certificates Earned' for future access.